Weekly Cannabis State Update (Oct. 19, 2026): Where License Availability Actually Moved
Weekly Cannabis State Update (Oct. 19, 2026): Where License Availability Actually Moved
Quick answer: Federal timelines did not move. DEA Chief Administrative Law Judge Derek Julius kept marijuana rescheduling stayed and gave DEA until October 21, 2026 to respond to a bid to reopen testimony. The license-availability news is state-level: Nebraska will issue no new manufacturer, transporter or dispensary licenses until new fee rules clear the Governor and AG, possibly slipping into 2027; Massachusetts Question 8 could repeal adult-use licensing; Virginia targets retail applications by February 1, 2027.
Key takeaways:
- On October 14, 2026, DEA Chief ALJ Derek Julius kept the rescheduling proceeding stayed and gave DEA until October 21, 2026 (10-page limit) to respond to opponents’ motion to reopen testimony and discovery.
- Nebraska’s Medical Cannabis Commission heard proposed fees on October 15, 2026 — a $5,000 application fee, annual license/renewal fees of $10,000–$28,500 by license type, a $1,500 relocation fee, a $13,000 seed-to-sale tracking fee, and a $250 per-product dispensary fee plus a $100 renewal fee — and will license no new manufacturers, transporters or dispensaries until those rules are final.
- South Dakota Attorney General Marty Jackley’s October 13, 2026 opinion concludes federal Schedule III placement requires no change to the state’s medical marijuana program.
- Massachusetts Question 8 would repeal the state’s adult-use dispensary licensing and taxing framework; on October 16, 2026, 63 state legislators endorsed the campaign against it.
Five items this week, and only one of them is federal. That is the pattern applicants should be reading: the rescheduling docket keeps generating headlines while producing zero change to state licensing timelines, and the decisions that actually open, close or reprice a license are happening in Lincoln, Boston, Pierre and Virginia Beach.
Two of this week’s items are gates — Nebraska’s fee rulemaking and Massachusetts’ ballot question — where nothing issues and no capital should move until a named authority signs off. One is a calendar you can build around: Virginia’s retail licensing rollout is firming up for 2027. Here is what changed, and what each item means for your application plan.
What did the DEA judge actually decide on rescheduling?
The proceeding is still paused. The filings this week were about whether to reopen the record, not about the merits.
- On Monday, October 12, 2026, rescheduling opponents (NDASA, DUID Victim Voices, and Dr. Kenneth Finn) filed a joint brief arguing a recent GAO report justifies a “narrow reopening” of the Schedule I-to-III rescheduling hearing for new testimony and document discovery.
- On Tuesday, October 13, 2026, Smart Approaches to Marijuana (SAM) and the states of Idaho, Indiana, and Nebraska filed a competing brief arguing the GAO report instead supports keeping the record as-is.
- On Wednesday, October 14, 2026, DEA Chief Administrative Law Judge Derek Julius issued an order keeping the proceeding stayed and giving DEA until October 21, 2026 (10-page limit) to respond to the reopening motion.
Confidence: High — reporting comes from Marijuana Moment, the trade outlet tracking this docket in near real time; dates and filings are internally consistent across separate dispatches. See also Marijuana Moment’s October 15 report on Judge Julius’s order.
Consultant note: both camps are maneuvering over a late-breaking GAO report rather than resolving anything. Do not expect a rescheduling recommendation in the near term. The practical effect on state licensing timelines is still zero, and firms should keep underwriting deals on current Schedule I assumptions (280E, banking access) until DEA actually rules.
Why is Nebraska not issuing new licenses right now?
Because the fee structure is not final, and the Commission has said it will wait.
- On Thursday, October 15, 2026, the Commission held a public hearing (1 p.m., State Office Building, Lincoln) on proposed rule amendments that would impose fees on the previously free program for the first time: a $5,000 application fee; annual license/renewal fees of $10,000–$28,500 depending on license type; a $1,500 relocation fee; a $13,000 seed-to-sale tracking system fee; and a $250 per-product dispensary fee plus a $100 renewal fee.
- Written comments were accepted through 11:59 p.m. on October 15, 2026. The rules would also merge transporter licenses into manufacturer licenses and remove outdated “Schedule I” references now that cannabis sits in federal Schedule III.
- The Commission will not license new manufacturers, transporters, or dispensaries until the fee rules are finalized — a process requiring sign-off from Gov. Jim Pillen and AG Mike Hilgers that could slip into 2027.
Separately, reporting on October 14, 2026 described MahaMota Cultivation, the state’s first licensed cultivator (near Raymond, NE), nearing harvest with no licensed testing lab, manufacturer, or transporter yet available to move product — raising concern about product degrading in storage. The Commission’s next regular meeting was set for Monday, October 19, 2026.
Confidence: High — the Nebraska Examiner is a dedicated state-government news outlet; named commissioners, specific fee figures, and dates are internally consistent with its ongoing coverage of the program.
Consultant note: this is the clearest near-term signal for anyone planning a Nebraska entry. Budget for the proposed fee schedule now — it is unlikely to get cheaper — and treat the lack of licensed testing and transport infrastructure as a near-term operational risk for the state’s first cultivators. More detail in our Nebraska cannabis licensing update.
Does federal Schedule III change South Dakota’s medical program?
No. On October 13, 2026, Attorney General Marty Jackley released an opinion, requested by State Sen. John Carley (vice chair of the Legislative Medical Marijuana Oversight Committee), concluding that the federal move of marijuana to Schedule III under the Controlled Substances Act does not require any change to South Dakota’s medical marijuana program.
Jackley’s reasoning: federal rules already accommodate state medical programs regardless of scheduling, so the program continues operating under existing state law unchanged. The opinion notes any future changes to the program are a policy matter for the Legislature or voters — not something the opinion itself changes.
Confidence: High — direct reporting on a dated, official AG opinion, with a clear timestamp and explicit sourcing of who requested it and why.
Consultant note: this removes a theoretical compliance question for South Dakota operators and applicants. There is no gap to close because of federal rescheduling, and the program’s current licensing rules stand as-is. Any future change would need a legislative or ballot push — worth watching ahead of the 2027 session, but not an active process today. Background: our South Dakota legalization overview.
How serious is the Massachusetts repeal question for licensees?
Serious enough to gate capital decisions. Question 8 (“An Act to Restore Sensible Marijuana Policy”) would repeal the state’s adult-use dispensary licensing and taxing framework. Home cultivation would remain legal, and simple possession up to 1 oz (or 5g of concentrate) would stay legal with a $100 fine for 1–2 oz.
- On October 16, 2026, the “No on 8: Stop the Repeal” campaign announced endorsements from 63 state legislators, including Senate President Karen Spilka and House Speaker Ronald Mariano.
- The measure already qualified for the November 2026 ballot after the Supreme Judicial Court ruled in June 2026 that the Attorney General properly approved the petition, and the Ballot Law Commission rejected challenges in January and July 2026.
Confidence: High — a trade publication and the Boston Globe independently confirm the same October 16 endorsement announcement. See Cannabis Business Times and The Boston Globe.
Consultant note: passage would unwind the entire adult-use licensing and tax structure Massachusetts operators rely on, making this the single biggest licensing-framework risk in the state heading into November. Clients with MA adult-use interests should treat the ballot outcome as a go/no-go gate on new capital deployment until the vote is decided. Our running state file: Massachusetts cannabis program overview.
What does Virginia Beach’s zoning survey signal for 2027 applicants?
Tighter local buffers than the state floor. On October 15, 2026, Virginia Beach’s Cannabis Advisory Task Force launched an online survey, open through October 20, 2026, asking residents to weigh in on zoning for future retail cannabis stores — including buffer distances beyond the state’s 1,000-foot minimum from schools, daycares, and parks, minimum distance between stores, proposed operating hours, and whether cultivation in industrial/agricultural zones needs a conditional use permit.
- Final city recommendations are expected by February 2027.
- Statewide, the Virginia Cannabis Control Authority plans to open retail license applications by February 1, 2027, with the CCA board expected to approve final regulations in December 2026.
- The program envisions up to 350 retail stores, 100 microbusinesses, and 5 Tier V cultivation licenses, with sales targeted to start July 1, 2027.
- Separately, the CCA’s statewide medical marijuana patient-satisfaction survey (covering over 114,000 unique 2025 dispensary patients) closed October 16, 2026; results will inform possible future program changes, though none have been announced yet.
Confidence: Medium-High — both items are confirmed against dated primary articles; the zoning story relies on a secondary local-news aggregator (Hoodline) rather than the city or CCA’s own site directly, so a light re-check before citing specifics to clients is worthwhile. Patient survey detail via The Marijuana Herald.
Consultant note: Virginia Beach is signaling it intends to set tighter local buffers than the state’s statutory minimum — a pattern CBA has seen play out locality-by-locality in other adult-use rollouts. Applicants eyeing Virginia Beach specifically should watch for the city’s February 2027 recommendations before locking in site selection. More broadly, the state’s licensing timeline is firming up and belongs in client planning calendars now. See our Virginia cannabis licensing update.
What should applicants do with this week’s news?
Sort it by whether it changes a date, a dollar figure or a gate.
- Federal: change nothing. Keep underwriting on current Schedule I assumptions (280E, banking access) until DEA actually rules.
- Nebraska: rebuild your entry budget around the proposed fee schedule and assume real licensing activity may not start until 2027.
- South Dakota: no action required; existing licensing rules stand.
- Massachusetts: hold new adult-use capital deployment until the November vote resolves.
- Virginia: put December 2026 (final CCA regulations), February 1, 2027 (applications open) and July 1, 2027 (sales target) on the calendar, and defer Virginia Beach site selection until the city’s February 2027 recommendations.
Frequently Asked Questions
Did the DEA judge’s October order restart marijuana rescheduling?
No. On October 14, 2026, DEA Chief Administrative Law Judge Derek Julius issued an order keeping the proceeding stayed and giving DEA until October 21, 2026, with a 10-page limit, to respond to opponents’ motion to reopen testimony and document discovery. The practical effect on state licensing timelines is still zero.
When will Nebraska issue new medical cannabis licenses?
The Commission will not license new manufacturers, transporters, or dispensaries until the proposed fee rules are finalized. That process requires sign-off from Gov. Jim Pillen and AG Mike Hilgers and could slip into 2027. The proposed rules would also merge transporter licenses into manufacturer licenses.
What would Massachusetts Question 8 do to cannabis licenses?
Question 8 would repeal the state’s adult-use dispensary licensing and taxing framework. Home cultivation would remain legal, and simple possession up to 1 oz (or 5g of concentrate) would stay legal with a $100 fine for 1–2 oz. It qualified for the November 2026 ballot, and 63 state legislators have endorsed the campaign to defeat it.
When do Virginia retail cannabis license applications open?
The Virginia Cannabis Control Authority plans to open retail license applications by February 1, 2027, with the CCA board expected to approve final regulations in December 2026. The program envisions up to 350 retail stores, 100 microbusinesses, and 5 Tier V cultivation licenses, with sales targeted to start July 1, 2027.
How CBA Can Help
CBA tracks state and federal licensing triggers week by week — fee rulemakings, application windows, ballot measures and local zoning decisions — and translates each one into what it means for your specific entry plan and budget. If you are weighing a Nebraska entry, holding Massachusetts capital until November, or building toward Virginia’s February 1, 2027 application window, we can tell you what to prepare and when.
Call 1-602-290-9424 or email Info@TheCannabisBusinessAdvisors.com to talk through your position in any of these markets.